Mechanisms of formation of IgE-binding factors (soluble CD23)--I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights
- PMID: 2534424
- DOI: 10.1016/0161-5890(89)90054-0
Mechanisms of formation of IgE-binding factors (soluble CD23)--I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights
Abstract
IgE-binding factors (soluble CD23) are generally considered to have an Mr of 25,000-27,000. The present study first indicates that IgE-BFs with an Mr of 33,000 or 37,000 may also be produced by Fc epsilon R II bearing B cells, depending upon the culture conditions and the nature of the Fc epsilon R II bearing cells. Extending our previous observations that the Mr 25,000-27,000 IgE-BFs are derived from the cleavage of soluble Mr 37,000 precursors, we show here that this cleavage is specifically inhibited by iodoacetamide but not by several other protease inhibitors. The proteolytic enzyme involved in the cleavage of Mr 33,000-37,000 precursors into Mr 25,000-27,000 IgE-BFs is cell-associated and is specifically expressed on Fc epsilon R II bearing cells. As expected, these Mr 33,000 and 37,000 fragments of Fc epsilon R II are capable of binding to IgE. The site at which these molecules are cleaved from Fc epsilon R II was located by determining their amino-terminal sequence. The Mr 37,000 IgE-BFs start at position 81 (glutamine) and the Mr 33,000 IgE-BFs start at position 102 (leucine) of the Fc epsilon R II sequence. Taken collectively, the present study not only contributes to our understanding of the mechanisms of formation of IgE-BFs, but also provides a means to prepare different molecular forms of IgE-BFs which may display different biological activity.
Similar articles
-
Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity.J Exp Med. 1990 Sep 1;172(3):693-700. doi: 10.1084/jem.172.3.693. J Exp Med. 1990. PMID: 2143772 Free PMC article.
-
Human Fc epsilon R II and IgE-binding factors.Int Arch Allergy Appl Immunol. 1989;88(1-2):18-22. doi: 10.1159/000234741. Int Arch Allergy Appl Immunol. 1989. PMID: 2523355 Review.
-
Presence of antigenic determinants common to Fc IgE receptors on human macrophages, T and B lymphocytes and IgE-binding factors.Immunology. 1986 Dec;59(4):569-75. Immunology. 1986. PMID: 2433216 Free PMC article.
-
Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.J Immunol. 1989 Jun 1;142(11):3901-8. J Immunol. 1989. PMID: 2523938
-
IgE-binding factors: their possible role in the regulation of IgE synthesis.Ric Clin Lab. 1988 Apr-Sep;18(2-3):75-92. doi: 10.1007/BF02918876. Ric Clin Lab. 1988. PMID: 3062750 Review.
Cited by
-
Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.Immunology. 2001 Jul;103(3):319-31. doi: 10.1046/j.1365-2567.2001.01238.x. Immunology. 2001. PMID: 11454061 Free PMC article.
-
Immuno-evasive tactics by schistosomes identify an effective allergy preventative.Exp Parasitol. 2015 Jun;153:139-50. doi: 10.1016/j.exppara.2015.03.012. Epub 2015 Mar 24. Exp Parasitol. 2015. PMID: 25819297 Free PMC article.
-
Regulation of cytokine production by soluble CD23: costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release.J Exp Med. 1994 Sep 1;180(3):1005-11. doi: 10.1084/jem.180.3.1005. J Exp Med. 1994. PMID: 8064221 Free PMC article.
-
Expression, regulation and function of human Fc epsilon RII (CD23) antigen.Immunol Res. 1992;11(3-4):260-72. doi: 10.1007/BF02919132. Immunol Res. 1992. PMID: 1287120 Review.
-
Partial characterization of natural and recombinant human soluble CD23.Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):819-24. doi: 10.1042/bj2860819. Biochem J. 1992. PMID: 1417742 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials